CV Sciences, Inc. (OTCMKTS:CVSI) Stock Short Interest Drops 93.9%

CV Sciences, Inc. (OTCMKTS:CVSI) was the recipient of a significant decline in short interest in September. As of September 15th, there was short interest totaling 6,360 shares, a decline of 93.9% from the August 31st total of 103,431 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 883,978 shares, the short-interest ratio is presently 0.0 days.

CV Sciences Price Performance

CV Sciences stock traded up $0.00 during trading hours on Thursday, hitting $0.01. 1,233,798 shares of the stock were exchanged, compared to its average volume of 869,091. CV Sciences has a 12 month low of $0.01 and a 12 month high of $0.10. The business’s 50-day moving average is $0.02 and its two-hundred day moving average is $0.03.

CV Sciences Company Profile

CV Sciences, Inc is a consumer wellness company focused on hemp-derived cannabidiol (CBD) products. The company develops, manufactures and markets products intended to support general wellness, with its offerings sold primarily under the PlusCBD brand.

The PlusCBD portfolio has included CBD oils and tinctures, softgels, gummies and other ingestible products, as well as topical formulations and products for pets. CV Sciences has emphasized research, product development and quality standards in the formulation and testing of its hemp-derived products.

CV Sciences distributes its products through e-commerce, specialty retailers and other consumer channels, primarily serving the U.S.